with the National Institutes of Health receiving 10.4 billion dollars thanks to the exceptional economic stimulus plan, all eyes are on the agency to see how the money will transform biomedical research in the next 2 years (or at least, scientists give the matter their full attention after the end of the frantic effort to ask for some of that cash themselves).
Speaking today at the American Association for Cancer Research annual meeting in Denver, Colorado, John Niederhuber, who leads the National Cancer Institute, detailed how his organization plans to spend part 1 $ 3 billion that comes his way. Americans "want better ways to prevent cancer; they want the first diagnosis, and they want new therapies with fewer side effects that turn cancer into a condition you can live with and not die," said Niederguber, according to a transcript of his speech.
How to accomplish this with a flurry of money in a short time?
well, Niederguber said, during fiscal 09 NCI will fund grants that hit the 16th percentile in magazines, a large improvement over the 12th percentile in progress. NCI is also push harder in translational medicine. Niederguber said it will expand the Cancer Genome Atlas to characterize all genomic changes in 20 to 25 cancers; create a "small national patient characterization centers network," which genetically characterize patients to something a number of medical centers like the Mayo clinic and Massachusetts General Hospital, are already moving to do; and create a network of "physical sciences-oncology centers" to gather nanobiologie, proteomics and systems biology. NCI discussed all these approaches for a number of months, but the expansion of the Cancer Genome Atlas is a strong vote of confidence for a certain project had criticized.
Niederguber also briefly addressed a concern for many NCI beneficiaries: What will happen once the money from the short recovery after 2 years, especially given that the NCI will fund grants 4 years. "It is for NCI caring and thoughtful financing risks initially" these projects knowing that they will not be supported by the stimulus money through their lives, Niederguber admitted. And "I think it falls, so our beneficiaries to come forward with only their strongest science" of -wishful thought maybe, since virtually all biomedical scientists seeking a slice of the stimulus plan.
0 Komentar